Gracemarie Bricalli

  • Citations Per Year
Learn More
Correspondence to Dr Alexandru Eniu; aleniu@iocn.ro INTRODUCTION Forty years ago, a group of physicians gathered in Nice, France, with a shared optimism for the promise of systemic therapies to treat cancer. This conference became the inaugural meeting of what is now the European Society for Medical Oncology (ESMO), which today convenes nearly 20,000(More)
Correspondence to Prof Fortunato Ciardiello; feedback@esmo.org INTRODUCTION Since 2002, WHO and ESMO’s proven track record of making progress to bridge the world of clinical oncology with the WHO’s cancer control policies has kept cancer high on the world’s political agenda. In 2013, after 10 years of working in partnership, ESMO was granted ‘official(More)
Oncology is driven by an exponentially increasing complexity. As an example, the use of molecular profiling or the determination of molecularly based biomarkers for the selection of the appropriate targeted therapy has now become routine in clinical practice. Such developments must be covered during education and integrated at all levels, from basic medical(More)
  • 1